v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Investment securities, fair value $ 1,623 $ 1,539
Investment securities, amortized cost basis 1,695 1,641
Net finance receivables 23,870 23,554
Financing receivable, allowance for credit loss 2,754 2,705
Restricted cash and restricted cash equivalents 742 684
Long-term debt 22,053 21,438
Other liabilities $ 652 $ 686
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 2,000,000,000 2,000,000,000
Common stock, shares issued (in shares) 118,856,988 119,360,509
Common stock, shares outstanding (in shares) 118,856,988 119,360,509
Treasury stock at cost (in shares) 16,803,289 16,060,384
Consolidated VIEs    
Net finance receivables $ 14,460 $ 13,985
Financing receivable, allowance for credit loss 1,668 1,633
Restricted cash and restricted cash equivalents 720 662
Long-term debt 12,678 12,384
Other liabilities $ 29 $ 31